For Immediate Release
Chicago, IL – December 6, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: UnitedHealth Group Inc. UNH, Blackstone Inc. BX, Cigna Corp. CI, Canadian National Railway Co. CNI and PG&E Corp. PCG.
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for UnitedHealth, Blackstone and Cigna
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc., Blackstone Inc. and Cigna Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
UnitedHealth shares have gained +16.6% over the past year against the Zacks Medical - HMOs industry’s gain of +18.3%. The company’s top line has been growing and the momentum should continue in the years ahead on the back of a strong market position, new deals, renewed agreements and expansion of service offerings.
According to the Zacks analyst’s estimate the revenue for 2022 will rise to 12% from the 2021 level. Its solid health services segment provides diversification benefits. UNH's Government business remains well-poised for growth. Adjusted net earnings per share are anticipated in the $21.85-$22.05 band, up from the prior projection of $21.40-$21.90. A sturdy balance sheet enables investments.
However, softness in commercial business due to COVID-induced volatilities persists. Rising operating costs are hurting margins. As such, the stock warrants a cautious stance.
(You can read the full research report on UnitedHealth here >>>)
Shares of Blackstone have underperformed the Zacks Financial - Miscellaneous Services industry over the past year (-36.8% vs. -18.9%). This reflects the company’s exposure to the uncertain macroeconomic environment, particularly the outlook for its substantial commercial real estate holdings.
However, Blackstone remains well-poised to benefit from its strong fund-raising ability, revenue mix and global footprint. Further, continued net inflows are likely to keep supporting Blackstone's AUM growth in the upcoming period. The buyout of DCI further enhanced its digital capabilities.
(You can read the full research report on Blackstone here >>>)
Cigna shares have outperformed the Zacks Insurance - Multi line industry over the past year (+58.4% vs. +5.3%). The company’s revenues have been increasing consistently for the past few years, driven by acquisitions, superior operating performance and a high-quality product portfolio. Business streamlining by divesting its life, accident and supplemental benefits businesses to Chubb helps it to focus on core growth areas.
Increasing medical membership on the back of a diversified product portfolio, wide agent network and superior service are major positives. The company has been resorting to prudent capital deployment moves. For 2022, Cigna expects adjusted income from operations to be at least $22.90 per share.
However, high leverage can affect its financial flexibility. Rising operating costs might dent the company's margins. As such, the stock warrants a cautious stance.
(You can read the full research report on Cigna here >>>)
Other noteworthy reports we are featuring today include Canadian National Railway Co. and PG&E Corp.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report